Functional, psychological, and emotional well-being is of utmost importance to cancer patients. Macmillan Cancer Support has published Move More, a report highlighting the benefits of exercise for enhancing quality of life (QOL) in cancer survivors. How exercise affects functional capacity, muscular strength, body composition, nausea, fatigue, personality functioning, mood states, self-esteem, and QOL are summarized in the report.
Individualized computer-delivered treatment (CDT) for the maintenance of smoking cessation after a quit attempt did not increase short- or long-term abstinence rates compared with standard treatment (ST) in a group of 303 daily smokers who received either CDT or ST in combination with pharmacotherapy. At 1 week, 1 month, 6 months, and 12 months, no significant differences were found between the groups.
The evidence backing the use of myeloid growth factors in patients at high risk for febrile neutropenia is solid, according to Jeffrey Crawford, MD, of Duke Cancer Institute, Durham, North Carolina.
Myeloid growth factors are the primary means of preventing chemotherapy-induced neutropenia. This often leads to febrile neutropenia, which can be fatal in 10% of patients, according to a database of more than 40,000 individuals. Concerns recently have been raised, however, that their use is associated with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML).
In a study funded by Pathwork Diagnostics, Inc., researchers found that using the company’s tissue of origin test for patients with hard-toidentify primary cancers enabled accurate diagnosis of the tumor in several cases and led to changes in treatment. Patients whose diagnosis was confirmed appeared less anxious.
Results 1 - 10 of 17